Italy· 039364017
CONBRIZA*28 cpr rivestite 20 mg
A bazedoxifene product containing bazedoxifene, registered in Italy by PFIZER EUROPE MA EEIG, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Bazedoxifene is registered in 10 of 19 countries.
Countries holding a registration under ATC G03XC02 (bazedoxifene), each read from that country’s own register.
- This record: Italy
- 6 of them publish a price we can compare per daily dose
Bazedoxifene · ATC G03XC02
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Polandprice
Price per daily dose
What a daily dose of bazedoxifene costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- Italy: $1.34 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Bazedoxifene · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- IT Italy$1.34
The record
At a glance
- Active substance
- Bazedoxifene
- Manufacturer
- PFIZER EUROPE MA EEIG
- Country
- Italy (IT)
- ATC code
- G03XC02
- ATC class
- Bazedoxifene
- Defined daily dose
- 20 mg, O
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic039364017CONBRIZA*28 cpr rivestite 20 mgEUR 32.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
6 interactions on record for bazedoxifene.
Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bazedoxifene · interactions on record
6 records
- 6 moderate
Most severe, free to view
- MegestrolG03AC05moderate
- MedroxyprogesteroneG03AC06moderate
- MedroxyprogesteroneG03DA02moderate
- MegestrolG03DB02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bazedoxifene in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCONBRIZAPfizer Europe MA EEIG, Bruxelles
- SpainCONBRIZA 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULAPfizer Europe Ma Eeig
- IrelandCONBRIZA 20 mg Film-coated tabletPfizer Europe MA EEIG
- IcelandConbrizaPfizer Europe MA EEIG*
- NetherlandsConbriza 20 mg, filmomhulde tablettenPfizer Europe MA EEIG
- PolandConbrizaPfizer Europe MA EEIG
- BelgiumConbriza 20 mgPfizer Europe MA
- SwedenCONBRIZA 20 mg Filmdragerad tablettPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Conbriza
- Liechtenstein · Conbriza
- Norway · Conbriza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32d7c8e6-1810-495e-81dd-4db75ffde9b9 GET /v1/drugs/32d7c8e6-1810-495e-81dd-4db75ffde9b9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 32.95,
"source": "aifa",
"currency": "EUR",
"strength": "BAZEDOXIFENE 20MG 28 UNITA' USO ORALE",
"substance": "Bazedoxifene",
"equivalence_group": "I1A",
"transparency_flag": null
}See everything about bazedoxifene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.